Navigation Links
BioMarin Announces Third Quarter 2010 Financial Results
Date:10/28/2010

or LEMS in the U.S. by early 2011.  If successful, NDA submission is expected in the first half of 2012, followed by approval by the end of 2012.
  • GALNS for MPS IVA: BioMarin expects to initiate a 24-week pivotal Phase III study with six-minute walk distance as the primary endpoint early in the first quarter of 2011.
  • Kuvan outcomes study/ Hand-Held Blood Phe Monitor: PKU-016, a randomized, placebo-controlled, 13-week Kuvan outcomes study is ongoing.  Endpoints include clinically validated measures of neuropsychiatric symptoms and if successful, may enable a label amendment.  Several other programs are underway to expand and protect the market and to improve the ability of healthcare providers and patients to better manage PKU.  These programs include a state-of-the-art handheld device to measure blood Phe levels in PKU patients. Regulatory approval and commercial availability of the handheld blood Phe monitor are expected in late 2011.

  • Mid-Stage Programs

  • PEG-PAL for PKU: The ongoing Phase II clinical trial is an open-label, multi-center study conducted in a series of dose-escalating cohorts.  The primary treatment period of eight weekly injections at a fixed dose is followed by dose and frequency optimization and an extension period.  All top-line results for the Phase II study, including a study comparing daily and weekly dosing and a formulation study are expected in mid-2011.  The company expects to initiate a Phase III trial in the fourth quarter of 2011 or the first quarter of 2012.

  • Preclinical Programs

  • BMN-673 (PARP inhibitor):  The company expects to file an IND for BMN-673 by the end of 2010 and initiate a Phase 1b trial in the first quarter of 2011.  BioMarin believes that, based upon internal preclinical experiments, BMN-673 may be ultimately superior to other compounds currently in clinical development.
  • '/>"/>

  • SOURCE BioMarin Pharmaceutical Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. BioMarin to Host a Research and Development Day on October 19th
    2. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
    3. BioMarin to Present at the UBS Global Life Sciences Conference
    4. BioMarin to Present at the Stifel Nicolaus Healthcare Conference
    5. BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease
    6. BioMarin Acquires ZyStor Therapeutics, Inc.
    7. BioMarin Initiates Phase 3b Study to Evaluate the Effects of Kuvan on Neurophychiatric Symptoms in Subjects with PKU
    8. BioMarin to Acquire LEAD Therapeutics
    9. BioMarin to Present at the Credit Suisse Healthcare Conference
    10. BioMarin Announces Third Quarter 2009 Financial Results
    11. BioMarin to Present at the Oppenheimer Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/22/2014)... Aug. 22, 2014  Cannabis Science, Inc. (OTC: ... drug development and related consulting, is pleased to ... medical cannabis conference taking place at the Faculty ... , on October 22, 2014.  The multilingual conference ... as researchers, health professionals, and patients, to discuss ...
    (Date:8/21/2014)... 21, 2014   Memorial Hermann Health System and ... today announced a new partnership to provide a new level ... care centers in the greater Houston ... become the exclusive provider of professional breast radiology services for ... Memorial City, The Woodlands , Northeast, Southwest ...
    (Date:8/21/2014)... , Aug. 21, 2014  Publicis Groupe customer ... , Managing Partner and Healthcare Industry Group Leader, has ... which recognizes the most inspiring people in the life-sciences ... in research and development, marketing, technology, creativity, strategy and ... 2006 as a partner in its leading Rosetta Consulting ...
    Breaking Medicine Technology:Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Shannon Hartley Shines in PharmaVOICE 100 2
    ... 13 Pacific Bridge Medical, a leading Asia medical consulting firm, ... 26, 2010 at 11am EDT . , ... Taiwan is the sixth largest pharmaceutical market in the Asia Pacific ... health care system. This webcast will give an overview of Taiwan and ...
    ... May 13 Omeros Corporation (Nasdaq: ... based on successful preclinical studies, the Company has selected ... has initiated the cGMP manufacturing development process in preparation ... proprietary, fully human, monoclonal MASP-2 antibodies shut down the ...
    Cached Medicine Technology:Pacific Bridge Medical to Host Taiwan Drug Registration Webinar 2Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders 2Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders 3Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders 4
    (Date:8/22/2014)... iFitDress.com, a well-known wedding dress manufacturer and retailer, has ... . In addition to this, the company’s sales representative ... with low shipping fees. , He says proudly, ... gowns. In our online store, there are thousands of ... What’s more, all of them are extremely beautiful. Most ...
    (Date:8/22/2014)... Medicine team has found that targeted automated alerts ... infections in hospital patients with urinary catheters. In ... simplified, the rate of improvement dramatically increased. , ... need urinary catheters in the first place and ... catheters that have not been removed within a ...
    (Date:8/22/2014)... 22, 2014 As the controversy ... ) in uterine surgeries continues to grow, Bernstein ... have decided to limit coverage of uterine morcellation. ... Blue Cross-Blue Shield of Massachusetts will no longer ... morcellation as of September 1, 2014. Other insurers ...
    (Date:8/22/2014)... August 22, 2014 Beat Eczema ... they can use natural methods to completely cure the ... the attention of Shane Michaels, prompting an investigative review. ... affects the skin, it can still be extremely debilitating ... Michaels. “The intense itching and pain that it causes ...
    (Date:8/22/2014)... the first time an oncogenic somatic mutation at amino ... has been identified in small cell lung cancer (SCLC) ... cell lines produced increased intracellular signaling and cell growth. ... cancer representing 15% of all lung cancers and is ... lung cancer, has been extensively examined for genomic alterations ...
    Breaking Medicine News(10 mins):Health News:Discounted Wedding Gowns For Sale At Leading Online Shop iFitDress.com 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 3Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 2Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 3Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 4Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2Health News:Novel oncogenic RET mutation found in small cell lung cancer 2
    ... to gather at the American Academy, of Pain Management,s 18th Annual ... ... Sept. 26 Pain is the number one,public health problem in ... Center for Health Statistics. The,number of people living with pain is ...
    ... favor of health insurance for low-income ... ... joined with a bi-partisan coalition of his colleagues today,and voted in favor ... I have been a supporter of both The Children,s Health,Insurance Program (CHIP) ...
    ... relax is at your fingertips, SAN DIEGO, Sept. ... -- Personal Input Pod(TM) -- a revolutionary biosensor that,helps ... applications that run on,Bluetooth(TM) enabled devices such as mobile ... of a unique stress management solution. It is,highly portable, ...
    ... of Cancer Care in, America; Cancer ... HOUSTON, Sept. 25 US Oncology, the nation,s,leading ... today expressed "deep concern" over a letter released ... (CMS) -- the agency which,manages the nation,s Medicare ...
    ... Supports Congressional Black Caucus,s ... Call to Action, ... today,s release of "We,re the,Ones We,ve Been Waiting For," its latest report ... doing about it. AIDS Action,Council also welcomes and supports the Call to ...
    ... State Funding, WOODLAND, Calif., Sept. 25 Homecare ... to increase funding for In-Home,Supportive Services, in order to ... people with disabilities. Workers represented by SEIU United ... a new contract to cover the,1,300 homecare workers in ...
    Cached Medicine News:Health News:Effective Pain Management Requires an Interdisciplinary Approach 2Health News:Effective Pain Management Requires an Interdisciplinary Approach 3Health News:Effective Pain Management Requires an Interdisciplinary Approach 4Health News:PIP - A Revolution in Stress Management 2Health News:PIP - A Revolution in Stress Management 3Health News:Cancer Doctors Across America 'Stunned' at Government's Ruling Restricting Anemia Management Protocols for Cancer Patients, Call Ruling 'Interference' in Practice of Medicine 2Health News:Cancer Doctors Across America 'Stunned' at Government's Ruling Restricting Anemia Management Protocols for Cancer Patients, Call Ruling 'Interference' in Practice of Medicine 3Health News:AIDS Action Council Praises Release of Latest State of AIDS in Black America Report 2Health News:Homecare Workers to Supervisors: Preserve Care of our Most Vulnerable 2
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: